|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 241/18 | (2006.01) |
| C07D 403/12 | (2013.01) | ||
| C07D 241/20 | (2006.01) | ||
| C07D 403/04 | (2013.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 241/18 | (2013.01) | ||
| C07D 403/04 | (2006.01) | ||
| C07D 241/20 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07D 477/26 | (2013.01) | ||
| C07D 487/04 | (2013.01) |
| (11) | Number of the document | 3484856 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17742609.5 |
| Date of filing the European patent application | 2017-07-11 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/041577 |
| Date | 2017-07-11 |
| (87) | Number | WO 2018/013597 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 201662361249 P | 2016-07-12 | US | |
| 201762449523 P | 2017-01-23 | US |
| (72) |
JOGALEKAR, Ashutosh , US
WON, Walter , US
KOLTUN, Elena S. , US
GILL, Adrian , US
MELLEM, Kevin , US
AAY, Naing , US
BUCKL, Andreas , US
SEMKO, Christopher , US
KISS, Gert , US
|
| (73) |
Revolution Medicines, Inc. ,
700 Saginaw Drive, Redwood City, CA 94063,
US
|
| (54) | 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS |
| 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS |